Giang Nguyen
Stock Analyst at Citi
(2.34)
# 3,078
Out of 5,020 analysts
15
Total ratings
58.3%
Success rate
4.2%
Average return
Main Sectors:
Stocks Rated by Giang Nguyen
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| LON: HIK Hikma Pharmaceuticals PLC | Reiterated: Buy | 1,700p → 1,870p | 1,571p | +19.03% | 2 | Aug 12, 2026 | |
| STO: SYNSAM Synsam AB (publ) | Reiterated: Buy | kr 75.00 → kr 70.00 | kr 51.40 | +36.19% | 2 | Jul 20, 2026 | |
| EPA: EL EssilorLuxottica Société anonyme | Reiterated: Buy | €339.00 | €144.60 | +134.44% | 1 | Dec 11, 2025 | |
| ETR: FRE Fresenius SE & Co. KGaA | Reiterated: Buy | €42.00 → €43.00 | €43.80 | n/a | 2 | Jan 31, 2025 | |
| ETR: FME Fresenius Medical Care AG | Reiterated: Hold | €41.00 → €46.50 | €39.68 | n/a | 2 | Jan 28, 2025 | |
| AMS: PHIA Koninklijke Philips N.V. | Reiterated: Hold | €28.50 → €27.00 | €21.20 | n/a | 2 | Jan 8, 2025 | |
| SWX: SOON Sonova Holding AG | Reiterated: Sell | n/a | $250.20 | n/a | 2 | Nov 21, 2024 | |
| LON: ONT Oxford Nanopore Technologies plc | Rated: Buy | 210p | 214p | n/a | 2 | Oct 1, 2024 |
Hikma Pharmaceuticals PLC
Aug 12, 2026
Reiterated: Buy
Price Target: 1,700p → 1,870p
Current: 1,571p
Upside: +19.03%
Synsam AB (publ)
Jul 20, 2026
Reiterated: Buy
Price Target: kr 75.00 → kr 70.00
Current: kr 51.40
Upside: +36.19%
EssilorLuxottica Société anonyme
Dec 11, 2025
Reiterated: Buy
Price Target: €339.00
Current: €144.60
Upside: +134.44%
Fresenius SE & Co. KGaA
Jan 31, 2025
Reiterated: Buy
Price Target: €42.00 → €43.00
Current: €43.80
Upside: n/a
Fresenius Medical Care AG
Jan 28, 2025
Reiterated: Hold
Price Target: €41.00 → €46.50
Current: €39.68
Upside: n/a
Koninklijke Philips N.V.
Jan 8, 2025
Reiterated: Hold
Price Target: €28.50 → €27.00
Current: €21.20
Upside: n/a
Sonova Holding AG
Nov 21, 2024
Reiterated: Sell
Price Target: n/a
Current: $250.20
Upside: n/a
Oxford Nanopore Technologies plc
Oct 1, 2024
Rated: Buy
Price Target: 210p
Current: 214p
Upside: n/a